In a cluttered suburban apartment east of Paris, health technician Vincent Mallet adjusts a plastic tube delivering oxygen to an elderly man’s diseased lungs. Sitting at the dining-room table, Mr. Mallet tests the equipment while the patient and his wife recount the daily struggles of living with chronic illness.

In the past, the couple would have made frequent visits to a nearby hospital. With Mr. Mallet now spending about an hour a week calibrating a bedside machine and writing a report for the man’s doctor as part of his rounds in the town of Fontenay-sous-Bois, those visits have become rare.

Mr. Mallet isn’t a nurse or physician. He’s an employee of Air Liquide SA, a French company better known for supplying gases in heavy cylinders and pipelines to industrial sites like refineries and steel plants. The visit to the patient, paid for by France’s state-funded medical system, is part of Air Liquide’s expanding health-care operations.

As factory demand softens and an oil slump hurts new industrial projects, big gas suppliers like Air Liquide SA, Linde AG and Praxair Ltd. have discovered they can profit from aging populations and an increase in chronic illness like asthma and diabetes. Linde serves 1.7 million home patients and says the global market for the kinds of health-care services it offers is on track to double over the 10 years to 2020, to 17 billion euros ($20 billion).

Advertise with us

“The potential for health care is huge, both in Europe and in emerging markets,’’ said Benoit Potier, CEO at Air Liquide, which serves 1.3 million patients. “Governments around the world are discovering that health care in the home can be cheaper and more effective than hospital stays.”

The gas companies were started more than a century ago by scientists who figured out how to liquefy and separate gases for industrial uses. Business boomed on demand for oxygen from steelmakers and nitrogen for chemical factories. As early as the 1930s, the companies began supplying hospitals with oxygen and nitrous oxide used as anesthesia. Since the 1980s, that has expanded to include home-health services.

“It’s possible health care will eventually overtake some of these companies’ industrial divisions,” said Baader Bank analyst Markus Mayer.

Air Liquide’s health-care sales have climbed at an average of 8 percent annually since 2011, and last year expanded at double the pace of its industrial operations. At Munich-based Linde, health-care services account for about a quarter of the gas division’s revenue and jumped by 7 percent in 2015 versus 0.5 percent growth for its industrial gas units.

“We will continue to reinforce our position as world leader’’ in home health care, Linde CEO Wolfgang Buechele told shareholders in Munich on May 3. Mr. Buechele has been pursuing what he calls an “internationalization” of the business, and the company now operates in 60 countries.

Advertise with us

The U.S. has become a key market for Linde, which last December agreed to buy Tennessee-based American HomePatient Inc. for 174 million euros. That followed the 2012 purchase of American health services provider Lincare Holdings Inc. — an erstwhile subsidiary that was separated from Linde in 1917 — for $3.8 billion.

The expansion into the U.S. has had its hiccups, exposing Linde to cuts in what Medicare pays for such services. Linde in December clipped its 2017 profit outlook partly due to falling prices in the U.S. Nevertheless, first-quarter earnings got a boost from the American HomePatient acquisition, which helped offset the price cuts that are expected to worsen in July, according to Bloomberg Industries.